Knock-in mice engineered to carry the E200K prion protein mutation, one of the changes that causes familial Creutzfeldt-Jakob disease in people, developed proteinase K-resistant misfolded prion protein (PrPSc) and spongiform degeneration in the brain after inoculation with fibrils assembled from purified prion protein alone, while hosts expressing wild-type prion protein did not. The finding, reported by Daniel Walsh, Heidi Standke, Allison Kraus, Joel Watts and Surachai Supattapone of Dartmouth's Geisel School of Medicine, Case Western Reserve University and the University of Toronto, was published in the Journal of General Virology on 5 February 2026. This is animal and laboratory work, not a study in people.

The distinction the paper turns on is what the inoculum contained. Prion protein converted in the test tube with polyanionic or lipid cofactors produces material with high specific infectivity in wild-type hosts; protein-only fibrils, formed with no cofactor added, have shown much lower specific infectivity in such hosts. The authors report that these protein-only preparations, of differing sequences, could nonetheless seed PK-resistant PrPSc and spongiform change in E200K mice, and conclude that the mutation raises host susceptibility to pure fibrils, pointing to differences in how wild-type and mutant prions replicate.

The host animals are not ordinary laboratory mice. They are knock-in lines expressing bank vole prion protein carrying the I109 variant, described by Mehra and colleagues in the Journal of Clinical Investigation on 1 August 2024. In that work, mice with wild-type bank vole prion protein stayed free of neurological disease, while a subset of those carrying the D178N or E200K mutations developed progressive illness with atypical protease-resistant prion protein, rather than the classical PK-resistant species seen in the new inoculation experiments.

The result is a susceptibility gradient written into the host's own sequence, and it does not travel further than that on this evidence. The fibrils are laboratory constructs, not prions taken from patients; the prion protein is bank vole, not human; and showing that mutant mice take up pure fibrils more readily is not the same as showing how genetic CJD or fatal familial insomnia begins in a person, where no inoculation occurs at all.